GLAXO · GlaxoSmithKline Pakistan Limited
Shariah Disclosure for the Half Year ended June 30, 2026
- Filed
- 15 September 2026 at 12:41 pm
- Category
- Financials
- Sentiment
- Neutral
- Impact
- Low
AI executive summary
GlaxoSmithKline Pakistan Limited submitted its Shariah disclosure for the half year ended June 30, 2026, reporting revenue earned from Shariah compliant business segments of PKR 31,519,292 thousand compared to PKR 30,300,807 thousand in the same period last year.
Key takeaways
- Revenue earned from Shariah compliant business segment was PKR 31,519,292 thousand for the half year ended June 30, 2026.
- Shariah-compliant bank balances stood at PKR 2,849 thousand as of June 30, 2026.
- Income on savings account - conventional was reported at PKR 359,963 thousand for the half year ended June 30, 2026.
Filing details
Dividend and entitlement
- Type
- None
- Notes
- The announcement is for Shariah Disclosure for the Half Year ended June 30, 2026, and does not declare any cash dividend, bonus, or rights entitlement.
- #shariah
- #disclosure
- #half-yearly
- #financial-results
This summary is AI-generated and may contain errors or omissions. Review the official PSX filing before making an investment decision.